In a recent article, Bu et al. (1) claim to describe a novel role for growth/differentiation factor 3 (GDF3) and the activin receptor–like kinase 7 (ALK7) in the regulation of adipose tissue lipolysis by insulin. It is an intriguing observation. I find, however, that several of the inconsistencies between the current study and previous studies from other laboratories, including mine (2,3,4), can be due to the authors' comparison of strains of mice that differ in many other genes besides Alk7, particularly given the way in which the Tsumura, Suzuki, obese diabetes strain and its derivatives were generated. In this regard, I find the conclusions made in this article about ALK7 function based on direct comparison of C57BL/6 and BALB/c mice particularly troublesome. These two strains of mice are totally different and diverge in dozens of genes, besides Alk7. It is invalid to make a claim about the function of a single gene based on phenotype comparisons of these two strains. The only way to be sure of the observations made by Bu et al. is to use gene-targeted approaches that affect the Alk7 gene specifically and nothing else. Such mouse strains have existed for many years, and it is not clear why the authors have not used them in the study. Moreover, the so-called Alk7-deficient mice used here are global mutants affecting all tissues from the time of conception. This severely limits the conclusions of the study, particularly with regard to insulin signaling. My group has previously shown that a global knockout of ALK7 affects many tissues besides fat, such as pituitary (5), hypothalamus (5), and the β-cells of the pancreas (4), which in fact secrete higher levels of insulin in the absence of ALK7 (4). No firm conclusion can be derived about tissue-autonomous roles of ALK7 in adipose tissue from a global mutant. I would strongly encourage Bu et al. to use Alk7 knockout and conditional mutant mice that specifically target the Alk7 gene to validate their studies, and we would be happy to provide those mice to them for that specific purpose. Until then, I would argue that the observations made by Bu et al. (1) can only be considered as preliminary. This concern is all the more urgent at this moment, when many observations made in the biomedical sciences are being questioned with all kinds of reproducibility problems, many of them arising from inappropriate animal models.

Duality of Interest. No potential conflicts of interest relevant to this article were reported.

1.
Bu
Y
,
Okunishi
K
,
Yogosawa
S
, et al
.
Insulin regulates lipolysis and fat mass by upregulating growth/differentiation factor 3 in adipose tissue macrophages
.
Diabetes
2018
;
67
:
1761
1772
2.
Guo
T
,
Marmol
P
,
Moliner
A
, et al
.
Adipocyte ALK7 links nutrient overload to catecholamine resistance in obesity
.
eLife
2014
;
3
:
e03245
3.
Andersson
O
,
Korach-Andre
M
,
Reissmann
E
,
Ibáñez
CF
,
Bertolino
P
.
Growth/differentiation factor 3 signals through ALK7 and regulates accumulation of adipose tissue and diet-induced obesity
.
Proc Natl Acad Sci U S A
2008
;
105
:
7252
7256
4.
Bertolino
P
,
Holmberg
R
,
Reissmann
E
,
Andersson
O
,
Berggren
P-O
,
Ibáñez
CF
.
Activin B receptor ALK7 is a negative regulator of pancreatic beta-cell function
.
Proc Natl Acad Sci U S A
2008
;
105
:
7246
7251
5.
Sandoval-Guzmán
T
,
Göngrich
C
,
Moliner
A
, et al
.
Neuroendocrine control of female reproductive function by the activin receptor ALK7
.
FASEB J
2012
;
26
:
4966
4976
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.